LSPOR offered a workshop with case studies about BIA and cost of illness on 24 Feb 2017.
The goal of our program for this annual meeting was to provide key concepts in Budget Impact Analysis (BIA) which is a tool to predict the financial impact of the adoption and diffusion of a new technology into a healthcare system with fixed resources. Payers are constantly requesting BIA alongside the CEA from pharmaceutical companies.
BIA is an essential part of a comprehensive economic assessment of a health care technology and is increasingly required, along with cost-effectiveness analysis (CEA), prior to formulary approval or reimbursement. The purpose of a BIA is to estimate the financial consequences of adoption and diffusion of a new health care intervention within a specific health care setting or system context given inevitable resource constraints.